PWRN2: A Non-Coding RNA Protein as A Potential Drug Target and Biomarker

Target Name: PWRN2

NCBI ID: G791115

PWRN2

Other Name(s): NCRNA00199 | Prader-Willi region non-protein coding RNA 2

PWRN2: A Non-Coding RNA Protein as A Potential Drug Target and Biomarker

PWRN2 (poly (W5-2) RNA-binding protein 2) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. PWRN2 is a key regulator of gene expression and has been shown to play a role in the development and progression of various diseases, including cancer.

PWRN2 Expression and Functions

PWRN2 is a highly conserved non-coding RNA molecule that is expressed in various tissues and cells throughout the body. It is primarily expressed in the brain and nervous system and has been shown to play a role in the development and progression of various neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and schizophrenia.

PWRN2 has also been shown to play a key role in the regulation of gene expression and has been shown to interact with a wide range of proteins, including transcription factors, RNA binding proteins, and metabolic enzymes. It is thought to function as a negative regulator of gene expression, which means that when PWRN2 is bound to a specific protein, it will prevent that protein from binding to its target RNA and will ultimately lead to reduced gene expression.

PWRN2 as a Drug Target

PWRN2 has been identified as a potential drug target due to its involvement in the regulation of gene expression and its role in the development and progression of various diseases. PWRN2 has been shown to play a role in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, as well as in the regulation of glucose metabolism and the development of cancer.

One of the main reasons for PWRN2's potential as a drug target is its conserved nature, as similar proteins have been identified in various species and have been shown to function similarly. This conservation suggests that PWRN2 may be a good candidate for drugs that target RNA-binding proteins, as these proteins are widely conserved and may be effective targets for small molecules.

Another potential mechanism by which PWRN2 may be targeted by drugs is its role in the regulation of gene expression. By interacting with various proteins, PWRN2 has been shown to regulate gene expression and can either enhance or suppress gene expression. This suggests that drugs that target PWRN2 may be able to disrupt its regulation of gene expression and lead to changes in gene expression levels that are beneficial or harmful to the target tissue or organism.

PWRN2 as a Biomarker

PWRN2 has also been identified as a potential biomarker for various diseases, including cancer. The detection and quantification of PWRN2 expression is an approach that can be used to monitor the effectiveness of cancer therapies and to evaluate the impact of those therapies on cancer cell proliferation.

PWRN2 has been shown to be expressed in various types of cancer cells, including breast, lung, and ovarian cancer cells. It has also been shown to play a role in the regulation of cancer cell growth and the development of cancer. This suggests that PWRN2 may be a useful biomarker for the diagnosis and treatment of various types of cancer.

PWRN2 Interactions with Other Proteins

PWRN2 has been shown to interact with a wide range of proteins, including transcription factors, RNA binding proteins, and metabolic enzymes. These interactions are important for the regulation of gene expression and are thought to play a key role in the development and progression of various diseases.

One of the most well-studied interactions between PWRN2 and a protein is its interaction with the transcription factor, PDGF-尾. PWRN2 has been shown to regulate the activity of PDGF-尾 and to play a role in the regulation of gene expression. This suggests that PWRN2 may be a

Protein Name: Prader-Willi Region Non-protein Coding RNA 2

The "PWRN2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PWRN2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets